Dennis Demont

Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency Profile

Tjeerd Barf, Todd Covey, Raquel Izumi et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 357 citations · Full text

Potency and Selectivity of BTK Inhibitors in Clinical Development for B-Cell Malignancies

Allard Kaptein, Gerjan de Bruin, Maaike Emmelot-van Hoek et al. · Blood · 2018 · 92 citations

Identification of Substituted 6-Amino-4-phenyltetrahydroquinoline Derivatives:  Potent Antagonists for the Follicle-Stimulating Hormone Receptor

Nicole C.R. van Straten, Twan H. J. van Berkel, Dennis Demont et al. · Journal of Medicinal Chemistry · 2004 · 81 citations · Full text

A new cleavage strategy for the solid-phase synthesis of secondary amines

Paolo Conti, Dennis Demont, Jos Cals et al. · Tetrahedron Letters · 1997 · 61 citations

Materials Science, Solid-phase Synthesis, Engineering +7

Structure-based lead identification of ATP-competitive MK2 inhibitors

Tjeerd Barf, Allard Kaptein, Sander de Wilde et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 22 citations · Full text

Medicinal Chemistry, Hit Identification, Biochemistry +8